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Much of the emphasis in the pathogenesis of 
diabetes mellitus has justifiably been placed on the 
endocrine gland, the pancreas. Extensive studies on 
the biosynthesis and release of insulin from the beta 
cell, bihormonal control of metabolism by insulin 
and glucagon, and more recently the role of soma-
tostatin have attracted the attention of students of the 
subject; but considerable evidence exists to suggest at 
least some role of tissue resistance to insulin in the 
pathogenesis of this disorder. There have been many 
advocates for extra-pancreatic factors causing dia-
betes. One of the first was Mirsky, who proposed that 
diabetes might be due to excessive amounts of hepatic 
insulinase, an enzyme which degrades insulin.' Val-
lance-Owen suggested that a circulating insulin an-
tagonist labeled synalbumin might be the cause of 
insulin resistance in diabetes.2 This factor was later 
shown to be an artifact. Others, such as Antoniades, 
proposed that insulin might circulate predominantly 
in a bound form in diabetic subjects and thus not 
exert full biologic activity.3 
The most articulate spokesman for a role of 
insulin resistance in diabetes mellitus in recent years 
has been Gerald Reavan, and his group from Stan-
ford University, who bases his theory on two obser-
vations. The first is that a large number, if not the 
majority, of adult onset diabetics have increased cir-
culating insulin concentrations rather than decreased 
concentrations as had been expected. This was first 
observed by Yalow and Berson shortly after the per-
fection of the radioimmunoassay for insulin.4 Hyper-
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insulinism in diabetics has since been confirmed by 
many investigators. A second observation supporting 
the role of insulin resistance in diabetes is that of 
"glucose impedance" in diabetic patients. Glucose 
impedance was demonstrated by Reaven and col-
leagues5 by infusing glucose and insulin at a constant 
rate in diabetic and non-diabetic subjects whose en-
dogenous insulin release had been shut off by admin-
istration of epinephrine and propranolol. New steady 
states for glucose and insulin were achieved in both 
groups, with comparable insulin concentrations in 
diabetics and non-diabetics, whereas the new steady 
state glucose concentration was considerably higher 
in diabetic subjects than in non-diabetic subjects . 
These excellent studies indicated that for a given con-
centration of insulin, the blood glucose-lowering ef-
fect was less in diabetics than in non-diabetic sub-
jects. More recently, Reaven and Olefsky have 
suggested that insulin resistance in diabetic patients 
might be due to a decrease in the number of insulin 
receptors6 by showing a decrease in the number of 
insulin receptors on circulating monocytes in diabetic 
patients compared to those on monocytes of non-
diabetic subjects . Additionally, treatment of their 
diabetic subjects with an oral hypoglycemic agent 
resulted in a return to normal of the number of 
insulin receptors on peripheral monocytes.7 A thor-
ough understanding of these latter observations and 
their obvious, important implications for the patho-
genesis of diabetes requires a certain knowledge of 
the insulin receptor and of recent advances in the 
field of receptor technology. 
Properties of the insulin receptor are shown in 
Table I. As is the case with other polypeptide hor-
mones, the receptor for insulin is located on the cell 
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TABLE I 
Properties of Insulin Receptors 
A) Located on cell membrane 
B) Unevenly distributed and may occur in clumps 
C) Protein with mo! wt approx. 300,000-Tetramer con-
sisting of monomers of 75,000 mol wt each 
D) Continuous synthesis and degradation with relatively 
slow turnover rate-2%/hr 
E) Presence of insulin receptor on cell membrane requires 
protein synthesis and microfilament integrity 
membrane. Evidence for intracellular distribution of 
insulin receptors is very scant; they are not evenly 
distributed over the cell surface but rather occur ran-
domly and in clumps at times.8 Present evidence sug-
gests that the insulin receptor is a protein with mo-
lecular weight of approximately 300,000. Studies 
performed at the National Institutes of Health from 
Dr. Jesse Roth's laboratory suggest that the insulin 
receptor is a tetramer consisting of monomers of 
75,000 dalton units each. Although the turnover rate 
is low compared to many biologic processes (2% per 
hour), continuous synthesis and degradation of the 
insulin receptor occurs. Studies with inhibitors of 
protein synthesis and microfilaments such as pur-
omycin and cytochalasin respectively indicate that 
protein synthesis and microfilarhent integrity are nec-
essary for the presence of insulin receptors on the cell 
membrane. 9 Inhibitors of microtubular function sur-
prisingly had no effect on insulin receptors. 9 
Knowledge of three concepts involving the in-
sulin receptor (Table 2) is of critical importance in 
interpreting studies in which receptor number and 
affinity have been determined. The number of recep-
tors per cell varies with the parti9ular cell being stud-
ied . However, for the peripheral monocyte, which is 
the most commonly studied cell in man because of its 
accessibility, the numbers of receptors vary between 
15,000 and 30,000 per cell. Clearly, only a fraction of 
the receptor sites must be occupied for biological 
activity, and the number of occupied sites required 
for the different activities of insulin may vary. For 
example, dose response data suggest that fewer sites 
must be occupied to inhibit lipolysis than to stimulate 
glucose oxidation. Thus, many of the insulin recep-
tors on the cell surface will be spare or unused recep-
tors. Recent investigations have even shown that 
some of these receptors rnay serve as a peripheral 
reservoir for insulin, · releasing intact insulin under 
appropriate circumstances. 10 
A second concept which is probably the most 
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important in understanding current receptor studies 
is that insulin inhibits insulin receptor number. Ex-
periments by Gavin et al 11 demonstrated that pre-
incubation of cultured lymphocytes with phys-
iological concentrations of insulin reduces the 
number of insulin receptors on these cells . An ob-
vious corollary of this finding would be the presence 
of decreased insulin receptors in states of hyperinsu-
linism such as obesity and some forms of diabetes. 
Although not reported yet, reduced insulin receptors 
would be anticipated in patients with islet cell tu-
mors. Thus, reduced receptor number might offer 
some protection to the patient with an islet cell tu-
mor. 
The third important concept in understanding 
insulin receptors is that of negative cooperativity. 12 
Simply stated, this concept refers to site interactions 
on the cell surf::ice by which affinity of the receptor 
for insulin is decreased as increasing numbers of re-
ceptors are occupied. This phenomenon might also 
be considered a homeostatic mechanism which pro-
tects the individual from the effects of hyperinsulin-
1sm. 
The insulin receptor perceives and either directly 
or through a transducer substance influences the ef-
fector for a specific activity. Insulin binding is the 
first step in biological activity of the hormone. Al-
though not all receptors are required for biological 
activity, more receptors increase the likelihood of 
binding for a given concentration of insulin . Binding 
of insulin to its receptor is therefore determined by 
insulin concentration, receptor number, and receptor 
affinity. Radioimmunoassay techniques for the mea-
surement of insulin have been available for years; 
now methods are available to measure insulin recep-
tor number and affinity. 
As mentioned the most accessible cells for mea-
suring insulin receptors in vivo are peripheral mon-
TABLE 2 
Important Concepts Involving Insulin Receptors 
A) Spare receptors 
I) Number of receptors per cell varies with cell type 
Peripheral monocytes have 15,000-30,000 receptors 
per cell 
2) Only small percentage of receptors must be occupied 
for biologic activity 
3) Spare receptors may serve as peripheral insulin 
reservoir 
B) Feedback inhibition of insulin receptor number by 
insulin 
C) Negative cooperativity 
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ocytes. These cells are obtained by Ficoll-Hypaque 
separation of the buffy coat of centrifuged blood. To 
determine receptor number and affinity, these cells 
are incubated with labeled insulin and increasing 
amounts of cold insulin, resulting in a binding curve 
(Fig I). Applying Scatchard analysis to this data 
results in a curvilinear plot (Fig 2B). Similar studies 
with the growth hormone receptors, or other hor-
mones not showing negative cooperativity, produce a 
linear Scatchard plot (Fig 2A ). Although th,e favored 
interpretation of the curvilinear Scatchard plot for 
insulin receptors is negative cooperativity, the possi-
bility that two types of insulin receptor sites (broken 
lines Fig 2) exist cannot be eliminated from present 
data. Employing Scatchard analysis, the number of 
receptors is calculated from the amount of bound 
insulin where the plot crosses the X axis . The slope of 
the plot reflects affinity, and new graphic analyses are 
available to express affinity even from a curvilinear 
plot.13 
Employing these techniques, insulin receptor 
number and affinity can be determined. The factors 
influencing affinity and receptor number are shown in 
Table 3. Some of these have already been discussed. 
One of the most important determinants of affinity is 
pH; its effect on insulin binding to receptors is shown 
in Figure 3. For both human monocytes and cultured 
lymphocytes, reducing pH from 7.4 to 6.8 results in 
greatly depressed insulin binding ahd may contribute 
to the insulin resistance observed in severe diabetic 
ketoacidosis. 
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Fig 1-1 nsulin binding to peripheral monocytes. 20 X I 0' mon-
onuclear cells ( 14% monocytes) were incubated in 0.5 ml buffer 
containing 50-100 pg 125 [-insulin and increasing amounts of unla-
beled insulin to give the final concentration indicated in the figure . 
After 3 hours incubation, 200 ul aliquots were centrifuged, aspi-
rated , and the sediment counted. 
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Fig 2-Scatchard analysis of binding data. B/ F = bound/ free 
radioactive ligand. Horizontal axis (Ro) is amount of ligand bound 
to receptor in molar quantities. A. Scatchard plot for hormone not 
exhibiting negative cooperativity; B. Plot is for hormone exhibiting 
negative cooperativity or having two different receptor sites. In-
sulin receptor studies show curvilinear plot as in B. 
The major factor so far uncovered altering in-
sulin receptor number is insulin acting in a type of 
feedback mechanism to inhibit insulin receptor num-
ber. Thus, as previousiy pointed out, reduced insulin 
receptors are anticipated in obesity where insulin re-
sistance and hyperinsulinism exist. Reduced insulin 
receptors have indeed been shown to occur in obese 
humans and animals. 1•- 16 In addition, dieting and 
weight reduction result in normalization of the num-
bers of insulin receptors .13 It is debatable whether 
reduced receptor concentration is primary, resulting 
in insulin resistance and hyperinsulinism, or whether 
insulin resistance due to some other factor is primary, 
causing hyperinsulinism and, secondarily, reduced in-
sulin receptors . 
Returning to Reavan and Olefsky's observations 
in non-obese diabetic subjects,6 it is not clear whether 
the reduced insulin recej".ltor number is due to the 
hyperinsulinism exhibited by this group [fasting im· 
munoreactive insulin (IRI) 20 ± 2 versus 10 ± I in 
normals] or whether it might be primary and thus be 
important pathogenetically. Nevertheless the de-
creased insulin receptors observed in the diabetic sub-
TABLE 3 
Determinants of lnslllin Binding to Tissues 
l. Receptor affinity 
PH 
Temperaiure 
Ionic strength 
Receptor occupancy (Negative cooperativity) 
ll. Receptor number 
Insulin decreases receptor number 
111. l nsulin concentration 
BLACKARD: INSULIN RECEPTORS 
35 
;::: 
z 25 
w 
~ 
w 
"-
<.'.) 
z 
i5 
Z 15 
iii 
:a 
::) 
:;a; 
x 
<I 
:a 
- PERIPHERAL CELLS 
o-o CULTURED CELLS (IM-91 
6.8 7.2 7.6 
pH OF INCUBATION MEDIUM 
8.0 8.4 
Fig 3-Effect of pH on insulin binding to receptors. Maximum 
binding refers to percent of 125 1-insµlin bound to receptors in the 
absence of unl abeled insulin. For peripheral cells 20 X IQ', mon-
onuclear cell s (14% monocytes) were used; cultured lymphoblas-
toid cells (IM-9) were used at 3.0 X 10' cells per ml concentration. 
jects in Reave n and Olefsky's study would certainly 
contribute to the insulin resistance observed. The 
return of receptor number to normal with chronic 
sulfonylurea treatment7 might in similar fashion be 
attributed to the reduced ' insulin concentrations in 
well-controlled diabetics on chronic sulfonylurea 
therapy. 
Although the role of reduced insulin receptors in 
the pathogenesis of di abetes mellitus is equivocal, a 
rare diabetic syndrome recently reported is clearly 
related to decreased insulin receptors. 17 In several 
patients with other evidence of immunologic disease 
associated with severe insulin resistance, an antibody 
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Fig 4-1 nsulin binding to peripheral monocytes from normal sub-
ject and patient wit h antibodies to the insu lin receptors. Details as 
for Fig I. 
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Fig 5-Effect of serum preincubation on insulin binding to cul-
tured lymphobl astoid cells (IM-9). IM-9 cells were preincubated 
with buffer, normal se rum, or se rum from insulin-resistant patient 
for 60 min , washed twice, and resuspended in 0.5 ml buffer at final 
concentration of 3 X 10' cells p~r ml. Binding curves were then 
ob tained on these ce lls. 
to the insulin receptor has been demonstrated. Since 
this report we at the Medical College of Virginia have 
had the opportunity to study two patients with this 
syndrome. One of the patients requiring over 2,000 
units of insulin daily had a strongly po~itive antinu-
clear antibody as the only other manifestation of 
autoimmunity; the second patient had a scleroderma-
like illness and required 1200 units of insulin daily . 
Insulin binding curves by peripheral monocytes from 
one of these patients is shown in Figure 4. That a 
serum factor was responsible for the decreased bind-
ing was indicated by studies in which cultured lym-
phocytes (IM-9) were preincubated with the pa-
tient's sera ( I : I 00) and then used for binding studies 
(Fig 5). Scatchard analysis (Fig 6) revealed the de-
creased binding to be due to a reduction in numbers 
of insulin receptors . Studies, not shown, in which 
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Fig 6-Sc11tchard ana lys is from binding data shown in Fig 5. 
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cultured lymphocytes were preincubated with IgG 
fraction of the patient's sera exhibited the same phe-
nomenon, suggesting that the serum contained an 
antibody to the insulin receptor. 
In summary, techniques are now available for 
measuring insulin receptors in vivo. So far, reduced 
insulin receptors have been observed in obese persons 
and in a selected group of adult onset diabetic pa-
tients. The pathogenetic significance of the latter ob-
servation is uncertain and may possibly be a manifes-
tation of the high insulin concentrations in these 
diabetics. However, a rare diabetic syndrome in 
which severe insulin resistance due to antibbdies to 
the insulin receptor has been reported and is now 
corroborated by our findings in two patients. 
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